Key result
Upper-extremity deep vein thrombosis management remains controversial and non-standardized, despite its increasing incidence and potential for considerable morbidity.
This review provides an overview of the etiology, pathogenesis, clinical features, and management of upper-extremity deep vein thrombosis, highlighting its increasing incidence and potential for considerable morbidity.
Underscores need for UEDVT consensus guidelines; leaves open optimal strategies pending prospective trials.
Prevention and treatment of lower-extremity deep vein thrombosis (LEDVT) has been the subject of many in-depth studies. Much less is known, however, about upper-extremity DVT (UEDVT). Previously considered as uncommon and benign, recent studies have demonstrated an increased incidence of UEDVT, partly attributable to the more frequent use of central venous catheters. This syndrome has the potential for considerable morbidity, including pulmonary embolism and persistent upper-extremity pain and swelling. Diagnostic imaging does not always confirm the precise location of the condition. Therapeutic intervention is still controversial, and therefore not standardized. This article aims to provide an overview of the aetiology, pathogenesis, and clinical features of UEDVT. The potential complications are presented, and therapeutic interventions discussed. The contribution of the nurse in the overall management of patients, including the detection and prevention of UEDVT, is also described.
No takes yet. Share an insight, caveat, or question.
Danny Meetoo (2010) conducted a review in Upper-extremity deep vein thrombosis. Upper-extremity deep vein thrombosis management remains controversial and non-standardized, despite its increasing incidence and potential for considerable morbidity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: